The 5-hydroxytryptamine type 3 (5-HT3) receptor is a member of the Cys-loop superfamily of ligand-gated ion channels (LGICs) and modulated by pharmacologic relevant concentrations of volatile anesthetics or n-alcohols like most receptors of LGICs. The goal of this study was to reveal whether the site-directed single mutations of E-106, F-107 and R-222 in 5-HT3 receptor may affect the anesthetic modulation of halothane known as positive modulator.
INTRODUCTION
The 5-hydroxytryptamine type 3 (5-HT3) receptor is a member of the Cys-loop superfamily of ligand-gated ion channels ( LGICs) that includes the nicotinic acetylcholine, glycine, and
[gamma]-amino butyric acid type A (GABAA) receptors. 1) Among the five subunits (A-E) cloned to date, 5-HT3A and 5-HT3B subunits have been demonstrated to have functional significance in the central and peripheral nervous systems. The 5-HT3B subunit must be coexpressed with the 5-HT3A subunit to be functional in peripheral nervous system, whereas the 5-HT3A subunit can form functional channels homomerically and such a homomer is predominantly expressed in central and peripheral nervous systems. [2] [3] [4] Receptors in superfamily of LGICs are comprised of a pentameric arrangement with each subunit containing a large extracellular N-terminal domain, four transmembrane domains (TM1-TM4), a large intracellular loop between TM3 and TM4, and an extracellular C-terminal domain. 5) The structure and function of LGICs is under intense investigation but still ambiguously defined. The ligand binding sites are thought to be located in the extracellular N-terminal domain at subunit-subunit interface, and the channel pore is believed to be formed by TM2. n-alcohols. 6, 7) Most volatile anesthetics, such as desflurane, isoflurane, halothane, enflurane and methoxyflurane potentiate 5-HT3 receptor at their human alveolar concentrations. [7] [8] [9] [10] [11] However, sevoflurane and two gaseous anesthetics (nitrous oxide, xenon) and intravenous anesthetics, such as pentobarbital and propofol, inhibited the 5-HT3A receptor. [11] [12] [13] Studies of chimera or single residue mutagenic recombinant receptors of
LGICs suggested that the function of LIGS was characterized by the N-terminal domain rather than transmembrane domains and C-terminal domain and channel gating sites are located in
TM2.
14) The majority of study of anesthetic modulation in
LGICs were focused in amino acid residues in TM2 associated with the channel gating. [15] [16] [17] [18] [19] But for the receptor to be activated, several amino acids in the proximal area of TM1 are also important for agonist recognition (glutamate 106 and phenylalanine 107 in N-terminal area) and possible coupling (arginine 222 in pre TM1 domain) between agonist binding and gating. [20] [21] [22] In chimeric receptor of N-terminal domain from nACh alpha 7 receptor and the TM and C-terminal domains from 5-HT3 receptor, modulation by isoflurane was involved the N-terminal domain of the receptor, which means that the anesthetic modulation in receptor may be also characterized by the N-terminal domain. 23) Considering that three amino acids in the proximal to TM1 domain of 5-HT3 receptor are important for agonist binding (glutamate 106 21) and phenylalanine 107 20) ) and coupling of agonist binding and channel gating (arginine 222 22) ), the anesthetic modulatory effect might be affected by the mutagenesis of the N-terminal domain of 
MATERIALS AND METHODS
Site-directed mutagenesis of the 5-HT3A cDNA A cDNA isolated from the mouse 5-HT3A receptor was generously provided by Dr. Jay Yang (Columbia University, USA). Seven kinds of mutant 5-HT3A receptor were constructed.
Glutamate (E) 106 was mutated into aspartate (E106D) or tyrosine (E106Y), phenylalanine (F) 107 into tyrosine (F107Y) or serine (F107S), and arginine (R) 222 into proline (R222P), phenylalanine (R222F) and valine (R222V), respectively.
For site-directed mutagenesis, sense and antisense primer oligonucleotides used were as following;
E106D
Sense primer oligonucleotides:
Anti sense primer oligonucleotides:
5'CCCCACGTCCACAAAGTCATTGATGAGAATGTCAG3' E106Y

Sense primer oligonucleotides:
5'TCCCTGACATTCTCATCAATTACTTTGTGGACGTGG-
GGAAG3'
5'CTTCCCCACGTCCACAAAGTAATTGATGAGAAT-
GTCAGGGA3' F107Y
Sense primer oligonucleotides:
' T G A C A T T C T C A T C A A T G A G T A C G T G G A C G T G-
GGGAAGTC3'
Anti sense primer oligonucleotides: The successful incorporation of mutation was verified by sequencing the clones using an automated DNA sequencer (Genetic Analyzer 3100, USA).
Expression of 5-HT3A receptors into Xenopus laevis oocytes
Wild-type and point mutant mouse 5-HT3A receptor cDNAs were subcloned into a custom oocyte expression vector, Oocytes were first preincubated with halothane for 2 min prior to application of 5-HT. Peak currents were recorded and compared to halothane-free controls. 5-HT (serotonin), collagenase IA, and almost all the chemicals were purchased from Sigma-Aldrich (USA). Halothane was purchased from Sigma-Aldrich (USA).
Data analysis
Peak currents induced by the drug applications were measured and concentration-response curves were fit (Sigmaplot v 7.0; SPSS Inc., USA) to the equation I/ Imax=C n /(C n ＋ EC50 n )
where I is normalized peak current form serotonin, and Imax is maximal normalized peak current. C is the concentration of serotonin, n is Hill coefficient and EC50 is the concentration at which half-maximal peak current is induced.
The inhibitory or potentiating effects of halothane were pre- 
Modulation of 5-HT EC20-induced currents by halothane according to wild-type and mutant 5-HT3A receptors
Halothane itself did not induce any current in wild and mutant receptors. LGICs seem to be the target receptors of anesthetic action.
Most studies of anesthetic mechanism are conducted in nACh receptor or GABAA receptors. Along with anesthetic mechanism on LGICs, anesthetics induced side effect such as postoperative nausea and vomiting has focused on the 5-HT3A
receptor.
LGIC member subunits share significant sequence homology and consists of a large, extracellular N-terminal domain, four transmembrane α-helical segments, and an intracellular component. 22, 24, 25) There have been many studies to identify amino acid residues critical for LGIC assembly, agonist affinity, and conductance. 5, 22, 26) The anesthetic effects on 5-HT3A receptors may not contribute to the establishment of an anesthetized state but be related to anesthetic induced nausea and vomiting. In vitro study, most volatile anesthetics, such as enflurane, halothane, isoflurane, enhanced 5-HT induced current in wild type 5-HT3A receptor with varying degree, but sevoflurane or propofol inhibited it. [7] [8] [9] [10] [11] 13) These findings are also noticeable in clinical studies.
Philip et al. 31) showed that the incidence of postoperative nausea and vomiting after ambulatory anesthesia was lower in the sevoflurane group than in the isoflurane group. Raeder et al. 32) reported that the incidence of postoperative nausea and vomiting was decreased following the use of propofol rather than desflurane after laparoscopic cholecystectomy. 5-HT3A receptors in the area postrema of the brain are believed to be associated with anesthetic associated nausea and vomiting. LGICs. 10, 15, [17] [18] [19] 25, 27, 35) The underlying mechanism how anesthetics interact with the
LGICs is assumed as an allosteric fashion. 36) As shown in the simplified kinetic scheme involving anesthetic modulation mechanism, allosteric modulation of anesthetics in 5-HT3A receptors might be achieved by altering agonist binding, the channel gating or linking both or desensitization.
In conclusion, this study has shown that mutation of glutamate 106 into aspartate in 5-HT3A receptor changed the direction of halothane modulation from positive to negative.
Mutations of phenylalanine 107 into tyrosine potentiated halothane modulation, while mutation of arginine 222 into phenylalanine or valine lost halothane modulation. These findings, conducted at the molecular level of 5-HT3A receptor, might indicate that anesthetic modulation in 5-HT3A receptor could be affected by the mutation of amino acid residues important for agonist binding and linking agonist to channel gating as well as channel gating.
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